Functional studies demonstrate that GPR65 is often overexpressed in solid tumours—including RCC—and that its activation enhances tumour cell survival under acidic conditions by engaging the cAMP-PKA and ERK signalling pathways—supporting continued proliferation even in the hostile TME [59,60,63,65]. Here, GPR65 is linked to renal cell carcinoma.